Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

CompletedOBSERVATIONAL

Enrollment

854

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Glaucoma, Open-AngleOcular Hypertension

Interventions

DRUG

bimatoprost 0.01%

Patients with POAG or OHT prescribed Lumigan® (bimatoprost 0.01%) treatment in a dose determined by the physician prior to study entry

Trial Locations (1)

Amsterdam